Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Liabilities and Shareholders Equity (2020 - 2025)

iSpecimen (ISPC) has 6 years of Liabilities and Shareholders Equity data on record, last reported at $9.0 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 20.12% year-over-year to $9.0 million; the TTM value through Sep 2025 reached $31.2 million, down 39.37%, while the annual FY2024 figure was $9.4 million, 40.89% down from the prior year.
  • Liabilities and Shareholders Equity reached $9.0 million in Q3 2025 per ISPC's latest filing, up from $6.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $35.7 million in Q4 2021 and bottomed at $6.0 million in Q2 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $18.2 million, with a median of $16.9 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: soared 475.22% in 2021, then tumbled 49.3% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $35.7 million in 2021, then plummeted by 31.08% to $24.6 million in 2022, then crashed by 35.74% to $15.8 million in 2023, then crashed by 40.89% to $9.4 million in 2024, then decreased by 3.77% to $9.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $9.0 million in Q3 2025, $6.0 million in Q2 2025, and $6.8 million in Q1 2025.